Medicines Formulary

Reports

Status	Drug name	NICE TAs	Comments
	Rubella vaccine
	Salbutamol inhaler
	Salbutamol injection
	Salbutamol nebulised
	Salbutamol oral
	Salicylic acid 16.7% with lactic acid 16.7% paint (Salactol®)
	Salicylic acid gel (Salatac®)
	Salicylic acid ointment (Verrugon®)
	Saliva artificial spray (Saliveze)		Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, Dental practitioners
	Salivix® pastilles		Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, dental practitioners.

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.